Medtronic (MDT) financial statements
+119.2%since 2013
- FY2026 revenue
- $36.4B▲ +8.4%
- FY2026 net income
- $4.8B▲ +3.0%
- FY2026 diluted EPS
- $3.73▲ +3.3%
- FY2026 free cash flow
- $5.4B▲ +4.6%
Medtronic income statement
| USD millions | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Period ended | 24 Apr 2026 | 25 Apr 2025 | 26 Apr 2024 |
| Revenue | 36,364 | 33,537 | 32,364 |
| Operating income | 6,467 | 5,955 | 5,144 |
| Pretax income | 6,136 | 5,628 | 4,837 |
| Net income | 4,801 | 4,662 | 3,676 |
| Diluted earnings per share | 3.73 | 3.61 | 2.76 |
Medtronic balance sheet
| USD millions | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Period ended | 24 Apr 2026 | 25 Apr 2025 | 26 Apr 2024 |
| Cash and cash equivalents | 1,949 | 2,218 | 1,284 |
| Total assets | 93,028 | 91,680 | 89,981 |
| Total liabilities | 42,956 | 43,424 | 39,561 |
| Total equity | 50,072 | 48,256 | 50,420 |
| Long-term debt | 26,173 | 25,642 | 23,932 |
Medtronic cash flow statement
| USD millions | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Period ended | 24 Apr 2026 | 25 Apr 2025 | 26 Apr 2024 |
| Operating cash flow | 7,330 | 7,044 | 6,787 |
| Capital expenditure | -1,904 | -1,859 | -1,587 |
| Free cash flow (derived) | 5,426 | 5,185 | 5,200 |
| Dividends paid | -3,639 | -3,589 | -3,666 |
| Share repurchases | -1,035 | -3,235 | -2,138 |
Quarterly highlights
| USD millions | Q1 FY2027 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 |
|---|---|---|---|---|
| Period ended | 31 Jul 2026 | 24 Apr 2026 | 23 Jan 2026 | 24 Oct 2025 |
| Revenue (derived) | 9,756 | 9,807 | 9,017 | 8,961 |
| Operating income (derived) | 1,764 | 1,873 | 1,464 | 1,686 |
| Net income (derived) | 1,470 | 1,244 | 1,143 | 1,381 |
| Diluted earnings per share | 1.14 | n/a | 0.89 | 1.07 |
| Operating cash flow (derived) | 1,793 | 2,573 | 2,744 | 925 |
| Total assets | 93,306 | 93,028 | 91,485 | 91,346 |
Medtronic major shareholders
| Holder | Share of class | Shares | Filed |
|---|---|---|---|
| Vanguard Capital Management | 7.5% | 96,424,044 | 28 April 2026 |
| BlackRock, Inc. | 6.9% | 88,655,585 | 24 April 2025 |
Medtronic 10-K and SEC filings
| Filed | Form | Type | Description |
|---|---|---|---|
| 19 October 2026 | 8-K | Current report | Current report |
| 17 September 2026 | 8-K | Current report | Current report |
| 3 September 2026 | 10-Q | Quarterly report | Quarterly report |
| 1 September 2026 | 8-K | Current report | Current report |
Common questions
What was Medtronic's revenue in fiscal 2026?
Medtronic reported $36.4 billion in revenue for fiscal 2026, the year ended 24 April 2026, up 8.4% from fiscal 2025.
What was Medtronic's net income in fiscal 2026?
Medtronic reported net income of $4.8 billion for fiscal 2026, the year ended 24 April 2026, up 3.0% from fiscal 2025. Diluted earnings per share were $3.73.
What was Medtronic's free cash flow in fiscal 2026?
Medtronic had $5.4 billion in free cash flow in fiscal 2026. Operating cash flow was $7.3 billion and capital expenditure was $1.9 billion.
What were Medtronic's total assets at the end of fiscal 2026?
Medtronic reported total assets of $93.0 billion at the end of fiscal 2026, the year ended 24 April 2026.
How much Medtronic history do I get?
Every account gets the full history, annual and quarterly, with first reported values and as of dates.
Start with a free key
$10 of free credit every month for 12 months. No card needed.$10 of free credit a month. No card needed.